Emilio Berti

bio-guoda/preston: 0.11.5

Michael Elliott, Jorrit Poelen, Alex Lancaster, Icaro Alzuru et autres

Features n/a Improvements favor anchored content in Zenodo over non-anchored content toward supporting IPBES metadata for Zenodo deposits @myrmoteras Bugs n/a

se, de (code pays fourni par la source)

European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders

Rein Willemze, Chalid Assaf, Martine. Bagot, Marie Beylot-Barry et autres

In recent classifications several cutaneous lymphomas were reclassified as lymphoproliferative disorder (LPDs). These include primary cutaneous CD4+ small/medium T-cell LPD (PCSM-TCLPD), primary cutaneous acral CD8+ T-cell LPD (acral CD8+ TCLPD) and primary cutaneous marginal zone lymphoma/LPD (PCMZL/LPD). The latter is still classified …

Klinische Ergebnisse von Chlormethin‐Gel bei Mycosis fungoides in “sensiblen” Bereichen: Eine retrospektive Fallserie

Gianluca Tavoletti, Gianluca Avallone, Pamela Vezzoli, Paolo Sena et autres

chlormethine, cutaneous lymphomas, Mycosis fungoides Sehr geehrte Herausgeber, Chlormethin (CL)-Gel ist das erste topische Therapeutikum, das zur Behandlung der Mycosis fungoides (MF) entwickelt wurde. 1 In internationalen Leitlinien wird es zur Erstlinientherapie für erwachsene Patienten mit MF im Frühstadium (IA-IIA) und in …

it (code pays fourni par la source)

Real-World Survival with Mogamulizumab versus Brentuximab in Advanced CTCL: insights from PROCLIPI

Elizabeth Peterknecht, Evangelia Papadavid, Alejandro Ariel Gru, Sean J Whittaker et autres

Nodes of concern? Prediction of nodal burden from radiological imaging in CTCL, findings from the PROCLIPI study

Alejandro Ariel Gru, M. Batistella, Emmilia Hodak, Sean J Whittaker et autres

A patchy prognosis: identification of prognostic factors associated with significant reduction in survival of early-stage Mycosis Fungoides patients

Julia Jane Scarisbrick, Sean J Whittaker, Christiane Querfeld, Maarten H. Vermeer et autres

Langerhans cell sarcoma is a clinically, biologically, and prognostically heterogeneous “malignant” histiocytosis: a systematic review of 88 cases from the literature

Annalisa Dezzani, Chiara Punziano, Emilio Berti, Arturo Bonometti

it (code pays fourni par la source)

European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders

Rein Willemze, Chalid Assaf, Martine Bagot, Marie Beylot-Barry et autres

In recent classifications several cutaneous lymphomas were reclassified as lymphoproliferative disorder (LPDs). These include primary cutaneous CD4+ small/medium T-cell LPD (PCSM-TCLPD), primary cutaneous acral CD8+ T-cell LPD (acral CD8+ TCLPD) and primary cutaneous marginal zone lymphoma/LPD (PCMZL/LPD). The latter is still classified …

nl, de, us, fr, it, be, at, es, ca, ch, ph, hu, cl, gr, gb (code pays fourni par la source)

A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification

Julia Jane Scarisbrick, Pietro Quaglino, Sean J Whittaker, Martine Bagot et autres

ABSTRACT: Advanced mycosis fungoides (MF) and Sézary syndrome (SS) have a poor overall survival (OS) of <5 years. Studies have found the current staging (IA-IVB) is inadequate for risk stratification. The PROCLIPI (Prospective Cutaneous Lymphoma International Prognostic Index) study was launched in …

gb, us, by, fr, gr, ch, au, br, es, it, be, ph, il, at, de, hu, fi, nl (code pays fourni par la source)

Clinical outcomes of chlormethine gel in mycosis fungoides affecting “sensitive” areas: A retrospective case series

Gianluca Tavoletti, Gianluca Avallone, Pamela Vezzoli, Paolo Sena et autres

Dear Editors,Chlormethine (CL) gel is the first skin-directed therapy developed for the treatment of mycosis fungoides (MF). 1 It is recommended as a first-line treatment for adult patients with early-stage MF (IA-IIA) and, in combination with systemic therapies, for those in advanced …

it (code pays fourni par la source)

A-230 Overlap: mycosis fungoides/Sezary syndrome and inflammatory dermatosis, a case series

Giorgio Alberto Croci, Silvia Maria Tabano, Italo Francesco Aromolo, Silvia Alberti Violetti et autres

A-249 Effectiveness and safety of chlormethine gel in the treatment of mycosis fungoides affecting “sensitive” areas: A real-world experience from two tertiary referral centres

Silvia Alberti Violetti, Gianluca Tavoletti, Gianluca Avallone, P. Vezzoli et autres